Recent policies reflect China’s goal of promoting patients’ ac- cess to innovative drugs. Note- worthy policy items include:

  • NMPA issued China Drug Regulatory Scientific Action Plan
  • NHSA released Work Plan for the 2019 Adjustment to the National Reimbursement Drug List (NRDL)
  • NHSA and MoF jointly released Notice on Key Tasks for the 2019 Basic Medical Insurance (BMI) System Development for Residents

The latest issue could be downloaded Here

Leave a comment